Sleeping sickness in Uganda: a thin line between two fatal diseases - PubMed (original) (raw)

Sleeping sickness in Uganda: a thin line between two fatal diseases

Kim Picozzi et al. BMJ. 2005.

Abstract

Objective: To determine, through the use of molecular diagnostic tools, whether the two species of parasite that cause human African trypanosomiasis have become sympatric.

Design: Blood sampling of all available patients between June 2001 and June 2005 in central Uganda and between July and September 2003 in northwest Uganda and analysis of subcounty sleeping sickness records in Uganda between 1985 and 2005.

Setting: Sleeping sickness treatment centres in central and northwest Uganda and in south Sudan.

Participants: Patients presenting at the treatment centres and diagnosed as having sleeping sickness.

Main outcome measure: Classification of parasites from patients from each disease focus as either Trypanosoma brucei rhodesiense (acute form) or T b gambiense (chronic form).

Results: Blood from 231 patients with sleeping sickness in central Uganda and from 91 patients with sleeping sickness in northwest Uganda and south Sudan were screened for T b rhodesiense (detection of SRA gene) and T b gambiense (detection of TgsGP gene). All samples from central Uganda were classified as T b rhodesiense, and all samples from northwest Uganda and south Sudan were identified as T b gambiense.

Conclusions: The two focuses of human African trypanosomiasis remain discrete, but the area of Uganda affected by the acute form of human sleeping sickness has increased 2.5-fold since 1985, spreading to three new districts within the past five years through movement of infected livestock. Without preventive action targeted at the livestock reservoir of this zoonotic disease, it is likely that the two disease focuses will converge. This will have a major impact on diagnosis and treatment of this neglected disease. Real time monitoring is recommended, using molecular diagnostic tools (at a regional surveillance centre, for example) targeted at both livestock and human patients.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Sequential maps of areas of Uganda affected by sleeping sickness. T b gambiense (in orange) occurs in south Sudan and northwest Uganda, where substantial human population movements have occurred as a result of civil instability. T b rhodesiense (in red) has been spreading since the mid-1980s, and its transmission is now occurring within 150 km of the T b gambiense active focus. The tsetse belt for Glossina fuscipes fuscipes extends right across the region

Comment in

Similar articles

Cited by

References

    1. Welburn SC, Odiit M. Recent developments in human African trypanosomiasis. Curr Opin Infect Dis 2002;15: 477-84. - PubMed
    1. Welburn SC, Fèvre EM, Coleman PG, Odiit M, Maudlin I. Sleeping sickness: a tale of two diseases. Trends Parasitol 2001;17: 19-24. - PubMed
    1. Hutchinson OC, Fèvre EM, Carrington M, Welburn SC. Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda. Lancet Infect Dis 2003;3: 42-5. - PubMed
    1. Paquet C, Castilla J, Mbulamberi D, Beaulieu MF, Etchegorry MG, Moren A. [Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda: evaluation of 5 years of control (1987-1991).] Bull Soc Pathol Exot 1995;88: 38-41. - PubMed
    1. Okiria R. The prevalence of human trypanosomiasis in Uganda, 1970 to 1983. East Afr Med J 1985;62: 813-6. - PubMed

Publication types

MeSH terms

LinkOut - more resources